Guangkang Biochemical announced that the company's wholly-owned subsidiary Hubei Shengkang Chemical's 2-nitro-3-methylbenzoic acid production plant and the fund-raising investment project “Special Chemical Construction Project with an annual output of 5,500 tons” have entered the trial production stage. The trial production period is from October 9, 2026 to October 8, 2027.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.